Model for End Stage Liver Disease and hepatocellular carcinoma: a moving target

Kenneth Washburn

Research output: Contribution to journalArticle

25 Scopus citations

Abstract

The institution of the Model for End Stage Liver Disease (MELD) score has been a successful refinement to the allocation for cadaveric liver allografts. Likewise, transplantation for patients with hepatocellular carcinoma (HCC) within defined criteria (Milan) has been shown to be very efficacious. The placement of patients with HCC in the allocation scheme with a MELD exception score has been an ongoing process of adjustments. The most recent data would suggest that patients with HCC continue to benefit from enhanced access to transplantation compared with patients without HCC. Development of a continuous HCC score, similar to the MELD score, maybe a more consistent and impartial way to equate access to cadaveric liver allografts for candidates with HCC and those without HCC.

Original languageEnglish (US)
Pages (from-to)11-17
Number of pages7
JournalTransplantation Reviews
Volume24
Issue number1
DOIs
StatePublished - Jan 1 2010

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'Model for End Stage Liver Disease and hepatocellular carcinoma: a moving target'. Together they form a unique fingerprint.

  • Cite this